Myocardial contrast echocardiography is a valuable technique for demonstration and delineation of regions of myocardial underperfu-
INTRODUCTION
Myocardial contrast echocardiography has been a major research objective in cardiovascular ultrasound studies for almost two decades. The assessment of myocardial perfusion by ultrasound -enhancing agents has been tested in different experimental and clinical settings, potentially adding a new dimension to echocardiography (Maurer, 2000) . Contrast echocardiography has contributed greatly to the understanding and in vivo identification of cardiac structures and physiological phenomena. The first contrast substances used were indocyanine green solution, saline, dextrose in water and the patient's blood. Progress in assessing myocardial perfusion by contrast echocardiography was related to the measurement of coronary flow reserve and to the evaluation of new ultrasound contrast agents (Schneider, 2000) . Therefore, myocardial contrast echocardiography has undergone extensive validation in experimental animals as a method for the in vivo detection and quantification of underperfused myocardium (Armstrong et al., 1982; Armstrong et al., 1983; Gertjan, et al., 2000; Kemper et al., 1983; Klipcera et al., 1982) .
In the 1970s and early 1980s contrast echocardiography played an important role in the validation of anatomic structures. A few years later a number of studies approved the use of contrast echo for delineating regional perfusion deficits (Kaul et al., 1984; Maurer, 2000) . Myocardial contrast echocardiography performed with sonicated diatrizoate meglumine (Renographin 76) or sonicated human albumin (Albunex®) can delineate areas of underperfused myocardium after coronary occlusion and in the presence of critical coronary artery stenosis (>75%).
The aim of this study was to determine whether a new contrast agent AQ-DDT, produced in the laboratory of the Institute for Cardiovascular Diseases of the Clinical Center of Serbia (Belgrade) and used during intraoperative echocardiography, could be valuable in the detection and quantification of regions of myocardial underperfusion resulting from coronary occlusion.
MATERIAL AND METHODS
Fourteen dogs weighing 18±5kg were anesthetized with sodium pentobarbital given intraperitoneally (30 mg/kg of body weight) and artificially ventilated by a CEP ASEARLE respirator. The heart was exposed through a medial sternotomy and pericardiectomy. For administration of contrast agent a modified pigtail catheter was placed through the right carotid artery and positioned in the proximal aorta just above the aortic valve. The left main (LM) and right coronary artery (RCA) were dissected free from surrounding tissues and O DEXON PLUS ties were placed around them. These ties were used to occlude the selected artery (for a period of 30 seconds); LM in seven dogs and RCA in the other seven. Continuous recordings were made on the electrocardiogram and, after the appearance of an elevated ST segment, occlusion of the artery was immediately stopped. There were no significant hemodynamic problems during the interventions. Only one dog had ventricular fibrillation during ligation of the RCA but it was successfully defibrillated.
Echocardiographic studies were made using a commercially available 5MHz transducer (Toshiba SSH 60). The transducer was protected with a sterile plastic bag and, for good resolution of the two-dimensional echo picture, sterile gel was put in this plastic bag and warm saline solution was poured over the exposed heart. Images of the left ventricle were obtained in a short axis crosssectional view at the mid-papillary muscle level. This view enables demonstration of three different coronary perfusion beds: the left coronary descending, left circumflex and right coronary artery. The imaging plane depth and gain settings were optimized in the position of the best visualization of the contrast effect at the beginning of the study and were not changed during the examination. All images before, during and after injections of contrast material were recorded on a VHS tape for later analysis. We used on original contrast agent AQ-DDT (aqueous solution of dense albumin) produced in the laboratory of the Institute for Cardiovascular Diseases of the Clinical Center of Serbia in Belgrade. Each dog received 3 injections of AQ-DDT and a volume of contrast agent sufficient for good opacification of the left ventricular myocardium, which was 1.0-2.5ml. Forty-two injections for perfusion analysis were made and scored by an investigator experienced in echocardiography, immediately and one month later. There was 100% agreement between these two scores.
The effects of contrast echocardiography were quantified as a good, poor and absent visualization. Good effects were defined as a clear demonstration of diffuse contrast flow in all segments of the left ventricle supplied by the investigated artery. The cases with partial (incomplete) demonstration of contrast distribution were scored as poor effects. Absent visualization was defined as complete absence of visualization of contrast.
RESULTS
The appearance of the myocardium before administration of contrast medium is shown in Figure 1 .
In dogs with normal coronary arteries (before occlusion), the entire myocardium was demonstrated as uniformly and simultaneously opacificated after injection of contrast agent. Proximal vascular beds of the coronary arteries in the first phase of contrast injection are shown in Figure 1A .
In dogs with coronary artery occlusion contrast echocardiography demonstrated persistent dark areas (Fig. 1B) , where contrast agent had been present before occlusion (Fig. 1A) .
The best quality images were obtained in the left coronary perfusion bed (Fig. 2) . This large vascular bed was completely demonstrated by the AQ-DDT contrast agent. Quantification of effects of myocardial contrast echocardiography before coronary occlusion is presented in Figure 3 .
It is obvious that in nearly 80% (78.6%) of the dogs without coronary occlusion the effects of the contrast agent we are good. Complete failure (absent visualization) was present in only 7.1% of these dogs. Scores of the effects of contrast echocardiography after coronary occlusion are presented in Figure 4 .
It is interesting that in these cases the effects of contrast agent in the remaining regions were increased, suggesting the existence of some compensatory mechanism to elevate blood flow in intact myocardial regions. Underperfused regions obviously were without visualization. 
DISCUSSION
Myocardial contrast echocardiography offers the potential to provide many types of information about myocardial perfusion (Schneider, 2000) . After myocardial infarction, it is a way of assessing infarct size and areas at risk. Also, it can help in studies of the no-reflow phenomenon, coronary flow reserve, the presence, extent and adequacy of the collateral circulation and of myocardial viability (Gertjan, et al., 2000; Kamp et al., 1989; Lindner et al., 2000; Maurer, 2000; Schneider, 2000) .
When micro bubbles of contrast agent are administered at the site of cardioplegia delivery, evaluation of regional differences in myocardial contrast effect can indicate the adequacy of intraoperative myocardial protection. The purpose is to minimize perioperative myocardial damage, to achieve adequacy of revascularization and to differentiate stunned from ischemic postoperative myocardial dysfunction (Aronson, 1993) . (Stunned myocardium is dysfunction with preserved perfusion and ischemic myocardium implies decreased function and perfusion). Hence, myocardial contrast echocardiography offers a unique, readily implementable opportunity to optimize coronary artery by pass grafting procedures (Villaneuva et al., 1992a).
The present study demonstrates the high quality of AQ-DDT as a contrast agent in the estimation of the size of areas of underperfused myocardium in the presence of complete coronary occlusion with an accuracy similar to those obtained by other different contrast agents (Almeida et Porter et al., 1999) . Also, our results indicate that myocardial perfusion with AQ-DDT contrast agent correlates well with the actual coronary anatomy in the dog.
The best quality of two-dimensional echo images was obtained in assessing the left coronary perfusion bed, which corresponds to the results of previous investigations. The sensitivity of contrast echocardiography in the detection of significant coronary stenosis in the septal or left anterior descendent region was shown to be 96% compared to 100% for the anterolateral or circumflex region and only 58% for the inferior or right coronary area (Cheirif et al., 1989; Galiuto and Iliceto, 1998; Goldman and Mindich, 1984; Ito et al., 1992; Jayaweera and Kaul, 1993) . It is harder to assess the right coronary artery system, since the particular echo view at the short axis mid-papillary muscle level may give a false echo contrast image of the posterior wall of the left ventricle. This problem of improvement of the effect of contrast visualization may be solved by direct administration of contrast into the coronary artery.
Several factors may influence the visualization of contrast agent during echocardiography: the nature of the agent, the way of its preparation, its temperature and rate of perfusion (Gertjan et al., 2000; Schneider, 2000; Tei et al., 1983) . Each of these factors might influence the quality of echo image in those of our cases with a poor effect of myocardial perfusion.
Our experimental results in dogs indicate that an albumin based original contrast agent (AQ-DDT) produces a good two-dimensional contrast echo image both for demonstration and good delineation of regional perfusion defects of the myocardium in dogs. We are sure that further clinical trials will confirm our conclusions about the suitability of AQ-DDT contrast agent in diagnosis and evaluation of the results of interventional therapy (coronary artery bypass graft or transluminal coronary angioplasty).
